Global Osteoarthritis Treatment Market by Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, Shoulder Osteoarthritis), by Drugs (Non-steroidal Anti-inflammatory Drugs (Non-steroidal Anti-inflammatory Drugs NSAIDs), by End User (Hospitals, Household, Clinics), by Therapies (Non-Pharmacological Therapy, Surgical Treatment, Pharmacological Therapy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Osteoarthritis Treatment Market research report which is segmented by Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, Shoulder Osteoarthritis), by Drugs (Non-steroidal Anti-inflammatory Drugs (Non-steroidal Anti-inflammatory Drugs NSAIDs), by End User (Hospitals, Household, Clinics), by Therapies (Non-Pharmacological Therapy, Surgical Treatment, Pharmacological Therapy), By Players/Companies Johnson & Johnson Limited, Pfizer Inc, Eli Lilly and Company, Novartis AG, GlaxoSmithKline plc, Sanofi SA, Bayer AG, Smith & Nephew Inc., Ampio Pharmaceuticals, Abiogen Pharma Spa, Zimmer Biomet, Regeneron Pharmaceuticals, Merck & Co, Anika Therapeutics., Abbott Laboratories”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Osteoarthritis Treatment Market Research Report |
| By Anatomy | Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, Shoulder Osteoarthritis |
| By Drugs (Non-steroidal Anti-inflammatory Drugs | Non-steroidal Anti-inflammatory Drugs NSAIDs |
| By End User | Hospitals, Household, Clinics |
| By Therapies | Non-Pharmacological Therapy, Surgical Treatment, Pharmacological Therapy |
| By Companies | Johnson & Johnson Limited, Pfizer Inc, Eli Lilly and Company, Novartis AG, GlaxoSmithKline plc, Sanofi SA, Bayer AG, Smith & Nephew Inc., Ampio Pharmaceuticals, Abiogen Pharma Spa, Zimmer Biomet, Regeneron Pharmaceuticals, Merck & Co, Anika Therapeutics., Abbott Laboratories |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 250 |
| Number of Tables & Figures | 175 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Osteoarthritis Treatment Market Report Segments:
The market is segmented by Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, Shoulder Osteoarthritis), by Drugs (Non-steroidal Anti-inflammatory Drugs (Non-steroidal Anti-inflammatory Drugs NSAIDs), by End User (Hospitals, Household, Clinics), by Therapies (Non-Pharmacological Therapy, Surgical Treatment, Pharmacological Therapy).
Some of the companies that are profiled in this report are:
- Johnson & Johnson Limited
- Pfizer Inc
- Eli Lilly and Company
- Novartis AG
- GlaxoSmithKline plc
- Sanofi SA
- Bayer AG
- Smith & Nephew Inc.
- Ampio Pharmaceuticals
- Abiogen Pharma Spa
- Zimmer Biomet
- Regeneron Pharmaceuticals
- Merck & Co
- Anika Therapeutics.
- Abbott Laboratories
Osteoarthritis Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Osteoarthritis Treatment Market
Overview of the regional outlook of the Osteoarthritis Treatment Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Osteoarthritis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Osteoarthritis Treatment Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Knee Osteoarthritis
2. Hip Osteoarthritis
3. Ankle Osteoarthritis
4. Shoulder Osteoarthritis
7. By Drugs (Non-steroidal Anti-inflammatory Drugs:1. Non-steroidal Anti-inflammatory Drugs NSAIDs
8. By End User:1. Hospitals
2. Household
3. Clinics
9. By Therapies:1. Non-Pharmacological Therapy
2. Surgical Treatment
3. Pharmacological Therapy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Osteoarthritis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Osteoarthritis Treatment Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Osteoarthritis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Osteoarthritis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Osteoarthritis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Osteoarthritis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Osteoarthritis Treatment Market Size & Forecast, 2018-2028
4.5.1 Osteoarthritis Treatment Market Size and Y-o-Y Growth
4.5.2 Osteoarthritis Treatment Market Absolute $ Opportunity
Chapter 5 Global Osteoarthritis Treatment Market Analysis and Forecast by Anatomy
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Anatomy
5.1.2 Basis Point Share (BPS) Analysis by Anatomy
5.1.3 Absolute $ Opportunity Assessment by Anatomy
5.2 Osteoarthritis Treatment Market Size Forecast by Anatomy
5.2.1 Knee Osteoarthritis
5.2.2 Hip Osteoarthritis
5.2.3 Ankle Osteoarthritis
5.2.4 Shoulder Osteoarthritis
5.3 Market Attractiveness Analysis by Anatomy
Chapter 6 Global Osteoarthritis Treatment Market Analysis and Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Drugs (Non-steroidal Anti-inflammatory Drugs
6.1.2 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
6.1.3 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
6.2 Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
6.2.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
6.3 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
Chapter 7 Global Osteoarthritis Treatment Market Analysis and Forecast by End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End User
7.1.2 Basis Point Share (BPS) Analysis by End User
7.1.3 Absolute $ Opportunity Assessment by End User
7.2 Osteoarthritis Treatment Market Size Forecast by End User
7.2.1 Hospitals
7.2.2 Household
7.2.3 Clinics
7.3 Market Attractiveness Analysis by End User
Chapter 8 Global Osteoarthritis Treatment Market Analysis and Forecast by Therapies
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Therapies
8.1.2 Basis Point Share (BPS) Analysis by Therapies
8.1.3 Absolute $ Opportunity Assessment by Therapies
8.2 Osteoarthritis Treatment Market Size Forecast by Therapies
8.2.1 Non-Pharmacological Therapy
8.2.2 Surgical Treatment
8.2.3 Pharmacological Therapy
8.3 Market Attractiveness Analysis by Therapies
Chapter 9 Global Osteoarthritis Treatment Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Osteoarthritis Treatment Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Osteoarthritis Treatment Analysis and Forecast
11.1 Introduction
11.2 North America Osteoarthritis Treatment Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Osteoarthritis Treatment Market Size Forecast by Anatomy
11.6.1 Knee Osteoarthritis
11.6.2 Hip Osteoarthritis
11.6.3 Ankle Osteoarthritis
11.6.4 Shoulder Osteoarthritis
11.7 Basis Point Share (BPS) Analysis by Anatomy
11.8 Absolute $ Opportunity Assessment by Anatomy
11.9 Market Attractiveness Analysis by Anatomy
11.10 North America Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
11.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
11.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
11.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
11.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
11.14 North America Osteoarthritis Treatment Market Size Forecast by End User
11.14.1 Hospitals
11.14.2 Household
11.14.3 Clinics
11.15 Basis Point Share (BPS) Analysis by End User
11.16 Absolute $ Opportunity Assessment by End User
11.17 Market Attractiveness Analysis by End User
11.18 North America Osteoarthritis Treatment Market Size Forecast by Therapies
11.18.1 Non-Pharmacological Therapy
11.18.2 Surgical Treatment
11.18.3 Pharmacological Therapy
11.19 Basis Point Share (BPS) Analysis by Therapies
11.20 Absolute $ Opportunity Assessment by Therapies
11.21 Market Attractiveness Analysis by Therapies
Chapter 12 Europe Osteoarthritis Treatment Analysis and Forecast
12.1 Introduction
12.2 Europe Osteoarthritis Treatment Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Osteoarthritis Treatment Market Size Forecast by Anatomy
12.6.1 Knee Osteoarthritis
12.6.2 Hip Osteoarthritis
12.6.3 Ankle Osteoarthritis
12.6.4 Shoulder Osteoarthritis
12.7 Basis Point Share (BPS) Analysis by Anatomy
12.8 Absolute $ Opportunity Assessment by Anatomy
12.9 Market Attractiveness Analysis by Anatomy
12.10 Europe Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
12.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
12.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
12.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
12.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
12.14 Europe Osteoarthritis Treatment Market Size Forecast by End User
12.14.1 Hospitals
12.14.2 Household
12.14.3 Clinics
12.15 Basis Point Share (BPS) Analysis by End User
12.16 Absolute $ Opportunity Assessment by End User
12.17 Market Attractiveness Analysis by End User
12.18 Europe Osteoarthritis Treatment Market Size Forecast by Therapies
12.18.1 Non-Pharmacological Therapy
12.18.2 Surgical Treatment
12.18.3 Pharmacological Therapy
12.19 Basis Point Share (BPS) Analysis by Therapies
12.20 Absolute $ Opportunity Assessment by Therapies
12.21 Market Attractiveness Analysis by Therapies
Chapter 13 Asia Pacific Osteoarthritis Treatment Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Anatomy
13.6.1 Knee Osteoarthritis
13.6.2 Hip Osteoarthritis
13.6.3 Ankle Osteoarthritis
13.6.4 Shoulder Osteoarthritis
13.7 Basis Point Share (BPS) Analysis by Anatomy
13.8 Absolute $ Opportunity Assessment by Anatomy
13.9 Market Attractiveness Analysis by Anatomy
13.10 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
13.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
13.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
13.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
13.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
13.14 Asia Pacific Osteoarthritis Treatment Market Size Forecast by End User
13.14.1 Hospitals
13.14.2 Household
13.14.3 Clinics
13.15 Basis Point Share (BPS) Analysis by End User
13.16 Absolute $ Opportunity Assessment by End User
13.17 Market Attractiveness Analysis by End User
13.18 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Therapies
13.18.1 Non-Pharmacological Therapy
13.18.2 Surgical Treatment
13.18.3 Pharmacological Therapy
13.19 Basis Point Share (BPS) Analysis by Therapies
13.20 Absolute $ Opportunity Assessment by Therapies
13.21 Market Attractiveness Analysis by Therapies
Chapter 14 Latin America Osteoarthritis Treatment Analysis and Forecast
14.1 Introduction
14.2 Latin America Osteoarthritis Treatment Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Osteoarthritis Treatment Market Size Forecast by Anatomy
14.6.1 Knee Osteoarthritis
14.6.2 Hip Osteoarthritis
14.6.3 Ankle Osteoarthritis
14.6.4 Shoulder Osteoarthritis
14.7 Basis Point Share (BPS) Analysis by Anatomy
14.8 Absolute $ Opportunity Assessment by Anatomy
14.9 Market Attractiveness Analysis by Anatomy
14.10 Latin America Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
14.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
14.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
14.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
14.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
14.14 Latin America Osteoarthritis Treatment Market Size Forecast by End User
14.14.1 Hospitals
14.14.2 Household
14.14.3 Clinics
14.15 Basis Point Share (BPS) Analysis by End User
14.16 Absolute $ Opportunity Assessment by End User
14.17 Market Attractiveness Analysis by End User
14.18 Latin America Osteoarthritis Treatment Market Size Forecast by Therapies
14.18.1 Non-Pharmacological Therapy
14.18.2 Surgical Treatment
14.18.3 Pharmacological Therapy
14.19 Basis Point Share (BPS) Analysis by Therapies
14.20 Absolute $ Opportunity Assessment by Therapies
14.21 Market Attractiveness Analysis by Therapies
Chapter 15 Middle East & Africa (MEA) Osteoarthritis Treatment Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Anatomy
15.6.1 Knee Osteoarthritis
15.6.2 Hip Osteoarthritis
15.6.3 Ankle Osteoarthritis
15.6.4 Shoulder Osteoarthritis
15.7 Basis Point Share (BPS) Analysis by Anatomy
15.8 Absolute $ Opportunity Assessment by Anatomy
15.9 Market Attractiveness Analysis by Anatomy
15.10 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
15.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
15.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
15.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
15.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
15.14 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by End User
15.14.1 Hospitals
15.14.2 Household
15.14.3 Clinics
15.15 Basis Point Share (BPS) Analysis by End User
15.16 Absolute $ Opportunity Assessment by End User
15.17 Market Attractiveness Analysis by End User
15.18 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Therapies
15.18.1 Non-Pharmacological Therapy
15.18.2 Surgical Treatment
15.18.3 Pharmacological Therapy
15.19 Basis Point Share (BPS) Analysis by Therapies
15.20 Absolute $ Opportunity Assessment by Therapies
15.21 Market Attractiveness Analysis by Therapies
Chapter 16 Competition Landscape
16.1 Osteoarthritis Treatment Market: Competitive Dashboard
16.2 Global Osteoarthritis Treatment Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Johnson & Johnson Limited
16.3.2 Pfizer Inc
16.3.3 Eli Lilly and Company
16.3.4 Novartis AG
16.3.5 GlaxoSmithKline plc
16.3.6 Sanofi SA
16.3.7 Bayer AG
16.3.8 Smith & Nephew Inc.
16.3.9 Ampio Pharmaceuticals
16.3.10 Abiogen Pharma Spa
16.3.11 Zimmer Biomet
16.3.12 Regeneron Pharmaceuticals
16.3.13 Merck & Co
16.3.14 Anika Therapeutics.
16.3.15 Abbott Laboratories
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Osteoarthritis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Osteoarthritis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Osteoarthritis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Osteoarthritis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Osteoarthritis Treatment Market Size & Forecast, 2018-2028
4.5.1 Osteoarthritis Treatment Market Size and Y-o-Y Growth
4.5.2 Osteoarthritis Treatment Market Absolute $ Opportunity
Chapter 5 Global Osteoarthritis Treatment Market Analysis and Forecast by Anatomy
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Anatomy
5.1.2 Basis Point Share (BPS) Analysis by Anatomy
5.1.3 Absolute $ Opportunity Assessment by Anatomy
5.2 Osteoarthritis Treatment Market Size Forecast by Anatomy
5.2.1 Knee Osteoarthritis
5.2.2 Hip Osteoarthritis
5.2.3 Ankle Osteoarthritis
5.2.4 Shoulder Osteoarthritis
5.3 Market Attractiveness Analysis by Anatomy
Chapter 6 Global Osteoarthritis Treatment Market Analysis and Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Drugs (Non-steroidal Anti-inflammatory Drugs
6.1.2 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
6.1.3 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
6.2 Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
6.2.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
6.3 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
Chapter 7 Global Osteoarthritis Treatment Market Analysis and Forecast by End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by End User
7.1.2 Basis Point Share (BPS) Analysis by End User
7.1.3 Absolute $ Opportunity Assessment by End User
7.2 Osteoarthritis Treatment Market Size Forecast by End User
7.2.1 Hospitals
7.2.2 Household
7.2.3 Clinics
7.3 Market Attractiveness Analysis by End User
Chapter 8 Global Osteoarthritis Treatment Market Analysis and Forecast by Therapies
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Therapies
8.1.2 Basis Point Share (BPS) Analysis by Therapies
8.1.3 Absolute $ Opportunity Assessment by Therapies
8.2 Osteoarthritis Treatment Market Size Forecast by Therapies
8.2.1 Non-Pharmacological Therapy
8.2.2 Surgical Treatment
8.2.3 Pharmacological Therapy
8.3 Market Attractiveness Analysis by Therapies
Chapter 9 Global Osteoarthritis Treatment Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Osteoarthritis Treatment Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Osteoarthritis Treatment Analysis and Forecast
11.1 Introduction
11.2 North America Osteoarthritis Treatment Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Osteoarthritis Treatment Market Size Forecast by Anatomy
11.6.1 Knee Osteoarthritis
11.6.2 Hip Osteoarthritis
11.6.3 Ankle Osteoarthritis
11.6.4 Shoulder Osteoarthritis
11.7 Basis Point Share (BPS) Analysis by Anatomy
11.8 Absolute $ Opportunity Assessment by Anatomy
11.9 Market Attractiveness Analysis by Anatomy
11.10 North America Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
11.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
11.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
11.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
11.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
11.14 North America Osteoarthritis Treatment Market Size Forecast by End User
11.14.1 Hospitals
11.14.2 Household
11.14.3 Clinics
11.15 Basis Point Share (BPS) Analysis by End User
11.16 Absolute $ Opportunity Assessment by End User
11.17 Market Attractiveness Analysis by End User
11.18 North America Osteoarthritis Treatment Market Size Forecast by Therapies
11.18.1 Non-Pharmacological Therapy
11.18.2 Surgical Treatment
11.18.3 Pharmacological Therapy
11.19 Basis Point Share (BPS) Analysis by Therapies
11.20 Absolute $ Opportunity Assessment by Therapies
11.21 Market Attractiveness Analysis by Therapies
Chapter 12 Europe Osteoarthritis Treatment Analysis and Forecast
12.1 Introduction
12.2 Europe Osteoarthritis Treatment Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Osteoarthritis Treatment Market Size Forecast by Anatomy
12.6.1 Knee Osteoarthritis
12.6.2 Hip Osteoarthritis
12.6.3 Ankle Osteoarthritis
12.6.4 Shoulder Osteoarthritis
12.7 Basis Point Share (BPS) Analysis by Anatomy
12.8 Absolute $ Opportunity Assessment by Anatomy
12.9 Market Attractiveness Analysis by Anatomy
12.10 Europe Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
12.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
12.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
12.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
12.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
12.14 Europe Osteoarthritis Treatment Market Size Forecast by End User
12.14.1 Hospitals
12.14.2 Household
12.14.3 Clinics
12.15 Basis Point Share (BPS) Analysis by End User
12.16 Absolute $ Opportunity Assessment by End User
12.17 Market Attractiveness Analysis by End User
12.18 Europe Osteoarthritis Treatment Market Size Forecast by Therapies
12.18.1 Non-Pharmacological Therapy
12.18.2 Surgical Treatment
12.18.3 Pharmacological Therapy
12.19 Basis Point Share (BPS) Analysis by Therapies
12.20 Absolute $ Opportunity Assessment by Therapies
12.21 Market Attractiveness Analysis by Therapies
Chapter 13 Asia Pacific Osteoarthritis Treatment Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Anatomy
13.6.1 Knee Osteoarthritis
13.6.2 Hip Osteoarthritis
13.6.3 Ankle Osteoarthritis
13.6.4 Shoulder Osteoarthritis
13.7 Basis Point Share (BPS) Analysis by Anatomy
13.8 Absolute $ Opportunity Assessment by Anatomy
13.9 Market Attractiveness Analysis by Anatomy
13.10 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
13.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
13.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
13.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
13.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
13.14 Asia Pacific Osteoarthritis Treatment Market Size Forecast by End User
13.14.1 Hospitals
13.14.2 Household
13.14.3 Clinics
13.15 Basis Point Share (BPS) Analysis by End User
13.16 Absolute $ Opportunity Assessment by End User
13.17 Market Attractiveness Analysis by End User
13.18 Asia Pacific Osteoarthritis Treatment Market Size Forecast by Therapies
13.18.1 Non-Pharmacological Therapy
13.18.2 Surgical Treatment
13.18.3 Pharmacological Therapy
13.19 Basis Point Share (BPS) Analysis by Therapies
13.20 Absolute $ Opportunity Assessment by Therapies
13.21 Market Attractiveness Analysis by Therapies
Chapter 14 Latin America Osteoarthritis Treatment Analysis and Forecast
14.1 Introduction
14.2 Latin America Osteoarthritis Treatment Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Osteoarthritis Treatment Market Size Forecast by Anatomy
14.6.1 Knee Osteoarthritis
14.6.2 Hip Osteoarthritis
14.6.3 Ankle Osteoarthritis
14.6.4 Shoulder Osteoarthritis
14.7 Basis Point Share (BPS) Analysis by Anatomy
14.8 Absolute $ Opportunity Assessment by Anatomy
14.9 Market Attractiveness Analysis by Anatomy
14.10 Latin America Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
14.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
14.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
14.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
14.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
14.14 Latin America Osteoarthritis Treatment Market Size Forecast by End User
14.14.1 Hospitals
14.14.2 Household
14.14.3 Clinics
14.15 Basis Point Share (BPS) Analysis by End User
14.16 Absolute $ Opportunity Assessment by End User
14.17 Market Attractiveness Analysis by End User
14.18 Latin America Osteoarthritis Treatment Market Size Forecast by Therapies
14.18.1 Non-Pharmacological Therapy
14.18.2 Surgical Treatment
14.18.3 Pharmacological Therapy
14.19 Basis Point Share (BPS) Analysis by Therapies
14.20 Absolute $ Opportunity Assessment by Therapies
14.21 Market Attractiveness Analysis by Therapies
Chapter 15 Middle East & Africa (MEA) Osteoarthritis Treatment Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Anatomy
15.6.1 Knee Osteoarthritis
15.6.2 Hip Osteoarthritis
15.6.3 Ankle Osteoarthritis
15.6.4 Shoulder Osteoarthritis
15.7 Basis Point Share (BPS) Analysis by Anatomy
15.8 Absolute $ Opportunity Assessment by Anatomy
15.9 Market Attractiveness Analysis by Anatomy
15.10 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Drugs (Non-steroidal Anti-inflammatory Drugs
15.10.1 Non-steroidal Anti-inflammatory Drugs NSAIDs
15.11 Basis Point Share (BPS) Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
15.12 Absolute $ Opportunity Assessment by Drugs (Non-steroidal Anti-inflammatory Drugs
15.13 Market Attractiveness Analysis by Drugs (Non-steroidal Anti-inflammatory Drugs
15.14 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by End User
15.14.1 Hospitals
15.14.2 Household
15.14.3 Clinics
15.15 Basis Point Share (BPS) Analysis by End User
15.16 Absolute $ Opportunity Assessment by End User
15.17 Market Attractiveness Analysis by End User
15.18 Middle East & Africa (MEA) Osteoarthritis Treatment Market Size Forecast by Therapies
15.18.1 Non-Pharmacological Therapy
15.18.2 Surgical Treatment
15.18.3 Pharmacological Therapy
15.19 Basis Point Share (BPS) Analysis by Therapies
15.20 Absolute $ Opportunity Assessment by Therapies
15.21 Market Attractiveness Analysis by Therapies
Chapter 16 Competition Landscape
16.1 Osteoarthritis Treatment Market: Competitive Dashboard
16.2 Global Osteoarthritis Treatment Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Johnson & Johnson Limited
16.3.2 Pfizer Inc
16.3.3 Eli Lilly and Company
16.3.4 Novartis AG
16.3.5 GlaxoSmithKline plc
16.3.6 Sanofi SA
16.3.7 Bayer AG
16.3.8 Smith & Nephew Inc.
16.3.9 Ampio Pharmaceuticals
16.3.10 Abiogen Pharma Spa
16.3.11 Zimmer Biomet
16.3.12 Regeneron Pharmaceuticals
16.3.13 Merck & Co
16.3.14 Anika Therapeutics.
16.3.15 Abbott Laboratories
Segments Covered in the Report
The global Osteoarthritis Treatment market has been segmented based on
By Anatomy
The global Osteoarthritis Treatment market has been segmented based on
By Anatomy
- Knee Osteoarthritis
- Hip Osteoarthritis
- Ankle Osteoarthritis
- Shoulder Osteoarthritis
- Non-steroidal Anti-inflammatory Drugs NSAIDs
- Hospitals
- Household
- Clinics
- Non-Pharmacological Therapy
- Surgical Treatment
- Pharmacological Therapy
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Johnson & Johnson Limited
- Pfizer Inc
- Eli Lilly and Company
- Novartis AG
- GlaxoSmithKline plc
- Sanofi SA
- Bayer AG
- Smith & Nephew Inc.
- Ampio Pharmaceuticals
- Abiogen Pharma Spa
- Zimmer Biomet
- Regeneron Pharmaceuticals
- Merck & Co
- Anika Therapeutics.
- Abbott Laboratories
Our Clients
Related Reports
Some other reports from this category!
